Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/35088
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThomson, W.-
dc.contributor.authorChalmers, J.-
dc.contributor.authorSpencer, A.-
dc.contributor.authorSlade, G.-
dc.date.issued2006-
dc.identifier.citationGerodontology: an international journal, 2006; 23(4):205-213-
dc.identifier.issn0734-0664-
dc.identifier.issn1741-2358-
dc.identifier.urihttp://hdl.handle.net/2440/35088-
dc.descriptionCopyright © 2006 The Gerodontology Association and Blackwell Munksgaard The definitive version is available at www.blackwell-synergy.com-
dc.description.abstractObjective: To describe the incidence of xerostomia among a population of older people over a 6-year period, with particular attention to medications as risk factors. Background: Understanding the natural history of xerostomia requires longitudinal epidemiological research, but only one study has examined changes in xerostomia over time. While medication is a recognised risk factor for dry mouth, the role of particular medication categories continues to be controversial. Materials and methods: Older South Australians (aged 60+) underwent an interview and dental examination at baseline, and these assessments were repeated 2, 5 and 11 years afterward. Medication data were collected at baseline, 5 and 11 years. Xerostomia data were collected at 5 and 11 years using the Xerostomia Inventory (XI) and a standard question. Results: Of the 1205 dentate participants assessed at baseline, 669 remained after 5 years, and 246 were assessed at 11 years. Medication prevalence increased over the observation period, such that 94.8% of the cohort were taking at least one medication by 11 years. The prevalence of xerostomia increased from 21.4% to 24.8% between 5 and 11 years (p > 0.05), and the mean XI score increased from 20.0 (SD, 6.7) to 21.5 (SD, 7.9; p < 0.001). Some 14.7% of participants were incident cases of xerostomia, while 11.4% were remitted cases; 10.1% were cases at both 5 and 11 years. After controlling for gender and ‘baseline’ xerostomia severity (represented by the XI score at 5 years), participants who commenced taking daily aspirin after 5 years had over four times the odds of becoming incident cases, while those who commenced taking a diuretic after 5 years had nearly six times the odds of doing so. Conclusions: While the overall prevalence of xerostomia increased during the observation period, there was considerable instability, with one-quarter of the cohort changing their status. Medication exposure was strongly associated with the incidence of the condition, with recent exposure to diuretics or daily aspirin strongly predicting it.-
dc.description.statementofresponsibilityW. Murray Thomson, Jane M. Chalmers, A. John Spencer, Gary D. Slade and Knute D. Carter-
dc.language.isoen-
dc.publisherFDI World Dental Press Ltd-
dc.source.urihttp://dx.doi.org/10.1111/j.1741-2358.2006.00135.x-
dc.subjectelderly-
dc.subjectxerostomia-
dc.subjectmedications-
dc.subjectcohort study-
dc.titleA longitudinal study of medication exposure and xerostomia among older people-
dc.typeJournal article-
dc.identifier.doi10.1111/j.1741-2358.2006.00135-
pubs.publication-statusPublished-
Appears in Collections:Aurora harvest 6
Dentistry publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.